Christopher J. Schaber - Jan 21, 2022 Form 4 Insider Report for SOLIGENIX, INC. (SNGX)

Role: CHAIRMAN, CEO AND PRESIDENT, Director
Signature: /s/ Christopher J. Schaber
Stock symbol: SNGX
Transactions as of: Jan 21, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/21/2022, 07:40 PM
Previous filing: Jan 4, 2022
Next filing: May 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SNGX	Option (Right to Buy)	Award	$0	+47.3K		$0.00	47.3K	Jan 21, 2022	Common Stock	47.3K	$0.69	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The terms of the stock option provide that it is to vest immediately as to 11,829 shares and to vest as to the remainder at a rate of 2,958 of the shares every three months, beginning on April 3, 2022; provided, however, that, consistent with the 2015 Equity Incentive Plan (the "Plan") and the rules of the Nasdaq Stock Market, such stock option shall not be exercisable nor shall it vest prior to the time when an amendment increasing the number of shares authorized for issuance under the Plan is approved by the stockholders, and provided further that, if such approval has not been obtained within 12 months of the grant date, the stock option shall thereupon be canceled and become null and void. The reporting person voluntarily agreed to cancel the stock option granted January 3, 2022 with respect to 47,315 shares.

Content

The terms of the stock option provide that it is to vest immediately as to 11,829 shares and to vest as to the remainder at a rate of 2,958 of the shares every three months, beginning on April 3, 2022; provided, however, that, consistent with the 2015 Equity Incentive Plan (the "Plan") and the rules of the Nasdaq Stock Market, such stock option shall not be exercisable nor shall it vest prior to the time when an amendment increasing the number of shares authorized for issuance under the Plan is approved by the stockholders, and provided further that, if such approval has not been obtained within 12 months of the grant date, the stock option shall thereupon be canceled and become null and void. The reporting person voluntarily agreed to cancel the stock option granted January 3, 2022 with respect to 47,315 shares.